» Articles » PMID: 21472733

Surgical Implications of Mesenteric Lymph Node Metastasis from Advanced Ovarian Cancer After Bowel Resection

Abstract

Background: Studies addressing mesenteric and mesocolic lymph node metastasis in patients with advanced ovarian cancer that have undergone bowel resection are lacking.

Methods: A retrospective analysis was performed in a series of 50 individuals who underwent surgical cytoreduction for epithelial ovarian cancer that included bowel resection from April 2004 to September 2010.

Results: Forty-one patients had bowel resection with mesenteric lymph nodes that were suitable for analysis. Twenty-four (58.5%) patients underwent retosigmoidectomies, 14 (34.1%) received other types of colectomies, and three (7.3%) underwent small bowel resection. There was serosal involvement in 14 cases (34.1%), muscularis propria invasion in 13 cases (31.7%), submucosa invasion in six cases (14.6%), and mucosa in eight cases (19.5%). Lymphatic invasion was observed in 24 patients (58.5%). A median of 14 mesenteric lymph nodes were analyzed. Metastatic lymph nodes were observed in 29 (70.7%) cases. Invasion into the muscularis propria (P = 0.036), lymphatic invasion (P = 0.045), and retroperitoneal lymph node metastasis (P = 0.002) correlated significantly with mesenteric lymph node involvement.

Conclusions: Resection of regional lymph nodes of affected organs that is similar to surgical procedures that are performed for colorectal carcinoma is an appropriate, optimal debulking surgery for patients with ovarian carcinoma.

Citing Articles

Prognostic Impact of Mesenteric Lymph Node Status on Digestive Resection Specimens During Cytoreductive Surgery for Ovarian Peritoneal Metastases.

Channawi A, Pop F, Khaled C, Gomez M, Moreau M, Polastro L Ann Surg Oncol. 2023; 31(1):605-613.

PMID: 37865938 PMC: 10695887. DOI: 10.1245/s10434-023-14405-3.


Prognostic Value of En-Block Radical Bowel Resection in Advanced Ovarian Cancer Surgery With HIPEC.

Panoskaltsis T, Papadimitriou C, Pallas N, Karamveri C, Kyziridis D, Hristakis C Cancer Control. 2023; 30:10732748231165878.

PMID: 36958947 PMC: 10041633. DOI: 10.1177/10732748231165878.


Clinical Significance of Mesenteric Lymph Node Involvement in the Pattern of Liver Metastasis in Patients with Ovarian Cancer.

Tanaka K, Shimada Y, Nishino K, Yoshihara K, Nakano M, Kameyama H Ann Surg Oncol. 2021; 28(12):7606-7613.

PMID: 33821347 DOI: 10.1245/s10434-021-09899-8.


Evaluation of the effects of hyaluronic acid-carboxymethyl cellulose barrier on ovarian tumor progression.

Picaud L, Thibault B, Mery E, Ouali M, Martinez A, Delord J J Ovarian Res. 2014; 7:40.

PMID: 24739440 PMC: 3996858. DOI: 10.1186/1757-2215-7-40.


Rectal lymph node metastasis in recurrent ovarian carcinoma: essential role of 18F-FDG PET/CT in treatment planning.

Kumagai K, Okamura T, Toyoda M, Senzaki H, Watanabe C, Ohmichi M World J Surg Oncol. 2013; 11(1):184.

PMID: 23938043 PMC: 3751651. DOI: 10.1186/1477-7819-11-184.